Article Per Year (5 Year)
p-Index From 2020 - 2025
0.444
P-Index
This Author published in this journals
All Journal Jurnal Kedokteran Anatomica (Anatomica Medical Journal) The Journal of Society Medicine (JSOCMED)
Resti, Riska
Unknown Affiliation
Dentistry Health Professions Immunology & microbiology Medicine & Pharmacology Neuroscience

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
A Study of Relationship Between Asthma Control Test, Lung Function, & Hospitalization Putra, M Yusuf Adira; Tarigan, Amira Permatasari; Pradana, Andika; Resti, Riska; Ramadhani, Adini Arifah; Nasution, Syafiah Amalina
Journal of Society Medicine Vol. 3 No. 12 (2024): December
Publisher : CoinReads Media Prima

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.47353/jsocmed.v3i12.179

Abstract

Introduction: The Asthma Control Test (ACT), developed in 2004, is a crucial tool for assessing asthma control. It facilitates discussions between patients and healthcare providers, guiding treatment decisions based on symptom severity. ACT evaluates symptoms over the past four weeks, while pulmonary function tests like forced expiratory volume in one second (FEV1) and peak expiratory flow (PEF) provide objective measures of airway function, offering complementary insights. Method: This cross-sectional study was conducted at Prof. Chairuddin Panusunan Lubis USU Hospital. Asthma patients were recruited, their characteristics documented through interviews, and spirometry was performed to assess lung function. Results: A significant proportion of patients had uncontrolled asthma based on ACT scores, which correlated with decreased lung function and higher risks of exacerbations. The study also explored characteristics of lung adenocarcinoma patients. Most were male (76.4%), heavy smokers (70.6%), and aged over 60 (52.9%). A majority (70.6%) were at Stage IVA, with pleural metastases being the most common. ALK mutations were detected in 5.8% of cases using immunohistochemistry. Conclusion: Achieving optimal asthma control remains a priority to reduce exacerbation risks and improve outcomes. ACT is a practical, patient-centered tool for identifying uncontrolled asthma and guiding management strategies. The adenocarcinoma findings highlight the need for early detection and targeted therapies in lung cancer care. These results reinforce the value of combining patient-reported outcomes and objective tests in disease management.
Profil Tatalaksana ICS/LABA pada Pasien Asma Persisten Sedang di Poliklinik Paru RS Prof. Chairuddin Panusunan Lubis Universitas Sumatera Utara Resti, Riska; Tarigan, Amira Permatasari; Pradana, Andika; Wahyuni, Arlinda Sari
ANATOMICA MEDICAL JOURNAL | AMJ Vol 8, No 2 (2025)
Publisher : Universitas Muhammadiyah Sumatera Utara

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30596/amj.v8i2.23821

Abstract

Asma adalah penyakit heterogen kronis yang paling umum pada saluran pernapasan di wilayah Asia-Pasifik dengan tingkat kontrol asma tertinggi adalah asma yang terkontrol sebagian yaitu 63%, diikuti oleh asma yang tidak terkontrol sebesar 30% dan asma yang terkontrol penuh sebesar 7%. Tujuan penelitian adalah untuk mengetahui profil penggunaan ICS/LABA berdasarkan tingkat kontrol asma. Penelitian dilakukan dengan metode retrospektif kohort analitik menggunakan 61 rekam medis dari 1 Januari 2017 hingga 31 Desember 2019. Subjek penelitian adalah pasien dengan asma persisten sedang yang menerima terapi ICS/LABA selama minimal 3 bulan. Analisis statistik deskriptif digunakan untuk menilai profil pengobatan ICS/LABA pada hasil klinis. Jenis kelamin didominasi oleh perempuan sebanyak 48 orang (78,7%), rentang usia 41-50 tahun sebanyak 20 orang (32,8%). Pada karakteristik pengobatan didominasi oleh ICS/LABA jenis Diskus Salmeterol/Fluticason propionat dosis 50/250 mcg sebanyak 33 orang (54,1%) dan ICS/LABA jenis Turbuhaler Formoterol Fumarat/Budesonide dosis 4,5/160 mcg sebanyak 28 orang (45,9%). Proporsi tingkat kontrol asma tertinggi adalah asma terkontrol sebagian sebanyak 44 orang (70,5%). Profil penatalaksanaan yang bervariasi didapatkan dengan mayoritas penggunaan ICS/LABA adalah jenis Diskus Salmeterol/Fluticason propionat dengan dosis 50/250 mcg.Kata Kunci : asma persisten sedang, ics/laba, profil tatalaksana
Co-Authors Andika Pradana Nasution, Syafiah Amalina Putra, M Yusuf Adira Ramadhani, Adini Arifah Tarigan, Amira Permatasari Wahyuni, Arlinda Sari